Effects of CD34 + cell dose on engraftment and long-term outcomes after allogeneic bone marrow transplantation.

Takashi OyamaShin-Ichiro FujiwaraRyutaro TominagaDaizo YokoyamaAtsuto NoguchiShuka FurukiShunsuke KoyamaRui MurahashiHirotomo NakashimaKazuki HyodoTakashi IkedaShin-Ichiro KawaguchiYumiko TodaTakashi NagayamaKento UminoDaisuke MinakataKaoru MoritaMasahiro AshizawaChihiro YamamotoKaoru HatanoKazuya SatoIkuko OtsukiKen OhmineYoshinobu Kanda

Published in: Clinical transplantation (2024)

cell dose in addition to NCC was useful for predicting hematopoietic recovery, but seemed to have little influence on the long-term outcome in BMT.

Keyphrases

bone marrow
cell therapy
single cell
mesenchymal stem cells
stem cell transplantation
hematopoietic stem cell
low dose